BriaCell Therapeutics Corp
BCTX
NSC
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
6.46
USD
-0.15
(-2.27%)
Optionable: No Market Cap: 100 M 90-day average vol: 363,704
Previous close: 6.61 Open: 6.54 Bid: 6.54 Ask: 6.54
52 week range
4.06 12.47
Peers
Last updated: Wednesday 10th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 0.00 |
Price per Book TTM ($) | 2.21 |
PE Ratio (TTM) | -3.30 |
Book Value per Share ($) | 3.78 |
5 Year PE Range-54.7 |
Returns
7 Day Return | -1.52% | |
1 Month Return | 8.75% | |
3 Month Return | 43.24% | |
1 Year Return | 13.93% | |
3 Year Return | 14923.26% | |
5 Year Return | 5342.29% | |
YTD Return | -21.98% |
Risk
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 54.11 |
14 Day SMA ($) | 6.50 |
14 Day EMA ($) | 6.47 |
Money Flow Index | 57.50 |
Average True Range | 0.35 |
50 Day SMA ($) | 6.04 |
200 Day SMA ($) | 7.56 |
ADX | 17.10 |
MACD | 0.15 |
Growth
Free Cash Flow QoQ Growth | 43.72% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | 50.00% |
Revenue QoQ Growth | 0.00% |
EPS YoY Growth | 0.00% |
Profitability
Peers
| Stock | Dividend | Market Cap (B) | PE | Price ($) |
|---|
Chart
News
BriaCell Adds Two Clinical Trial Sites to Accelerate Patient Enrollment
Yahoo Finance 2/28/2022
BriaCell Appoints Leading Immunologist Dr. Alexander Kharazi to its Scientific Advisory Board
Yahoo Finance 2/23/2022
BriaCell Appoints Renowned Oncologist, Giuseppe Del Priore, MD, MPH, as Chief Medical Officer
Yahoo Finance 2/16/2022
Bullish BriaCell Therapeutics Corp. (TSE:BCT) insiders were rewarded last week as their US$12m investment inflated to US$17m
Yahoo Finance 2/11/2022
BriaCell Virtually Opens the Market
Yahoo Finance 2/10/2022
BriaCell selected to present at upcoming medical event; updates on buyback program
Seeking Alpha 2/10/2022
BriaCell to Present at the AACR 2022; Provides Corporate Buyback and Insider Buying Update
Yahoo Finance 2/10/2022
Cancer immunotherapy developer Briacell slides 19% on 1.7x higher volume
Seeking Alpha 1/24/2022
BriaCell Therapeutics Corp. Announces Results of 2022 Annual and Special Meeting of Shareholders
Yahoo Finance 1/19/2022
TMX Group Equity Financing Statistics - December 2021
Yahoo Finance 1/11/2022
BCTX: Game, Set and Match: HLAs Score Success
Yahoo Finance 1/5/2022
BriaCell to uplist on the Toronto Stock Exchange
Seeking Alpha 12/30/2021
BriaCell to Uplist and Trade on the Toronto Stock Exchange from TSX Venture Exchange under 'BCT'; Remains 'BCTX' on Nasdaq
Yahoo Finance 12/30/2021
BriaCell says insiders to purchase up to 10% of its common stock
Seeking Alpha 12/16/2021
BriaCell Announces Insiders’ Intention to Purchase up to 10% of Public Market Securities
Yahoo Finance 12/16/2021
Briacell down 8% despite positive data on breast cancer candidate BRIA-IMT
Seeking Alpha 12/10/2021
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: 64.47
Financials
BCTX Income Statement
Annual
| Jul-12 | Jul-13 | Jul-14 | Jul-15 | Jul-16 | Jul-17 | Jul-18 | Jul-19 | Jul-20 | Jul-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of sales | -1722 | -393 | -1108 | -431 | -908 | -232 | -12974 | -14212 | -18741 | -15256 |
| Gross operating profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling Gen & administrative expense | 549297 | 425031 | 436310 | 2 M | 943495 | 873802 | 1 M | 975388 | 2 M | 6 M |
| Research & development expense | 0 | 0 | 0 | 297979 | 724562 | 2 M | 2 M | 4 M | 3 M | 1 M |
| Operating income | -551019 | -425425 | -437419 | -3 M | -2 M | -3 M | -4 M | -5 M | -5 M | -7 M |
| floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other income net | -481172 | 38769 | -8 M | -18805 | -32453 | -7132 | -331615 | 342739 | -96929 | 7 M |
| Pre-tax Income (EBT) | -994239 | -369710 | -8 M | -3 M | -2 M | -3 M | -4 M | -4 M | -5 M | -428334 |
| Income taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from total operations | -994239 | -369710 | -8 M | -3 M | -2 M | -3 M | -4 M | -4 M | -5 M | -428334 |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total net income | -994239 | -369710 | -8 M | -3 M | -2 M | -3 M | -4 M | -4 M | -5 M | -428334 |
| Preferred dividends | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net income available for common | -994239 | -369710 | -8 M | -3 M | -2 M | -3 M | -4 M | -4 M | -5 M | -428334 |
| Depreciation | 1722 | 393 | 1108 | 431 | 908 | 232 | 12974 | 14212 | 18741 | 15256 |
| Amortization | 1722 | 393 | 1108 | 0 | 0 | 232 | 12974 | 14212 | 15255 | 15254 |
| Operating income before depreciation (EBITDA) | -549297 | -425031 | -436310 | -3 M | -2 M | -3 M | -4 M | -4 M | -5 M | -366983 |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic EPS total | -19.44 | -9.49 | -134.12 | -11.46 | -9.2 | -7.2 | -9.72 | -6.83 | -6.99 | -0.09 |
| Diluted EPS total | -19.44 | -9.49 | -134.12 | -11.46 | -9.2 | -7.2 | -9.72 | -6.83 | -6.99 | -0.09 |
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!